Abstract

The epidermal involvement in American cutaneous leishmaniasis (ACL) was evaluated by an in situ characterization of epidermal Langerhans cells (LC), the expression of the major histocompatibility complex molecule HLA-DR and the intercellular adhesion molecule ICAM-1.